[1]CurrentPatentAssignee:UNIBIOSCREEN-WO2007/128538,2007,A1Locationinpatent:Page/Pagecolumn21
[1]CurrentPatentAssignee:UNIBIOSCREEN-WO2007/128538,2007,A1Locationinpatent:Page/Pagecolumn25
Title: UNBS5162, a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers.
Journal: Neoplasia (New York, N.Y.) 20080601
Title: Mijatovic T, et al. UNBS5162, a novel naphthalimide that decreases CXCL chemokine expression in experimental prostate cancers. Neoplasia. 2008 Jun;10(6):573-86.
Title: Tina Mahieu, et al. UNBS5162: A novel naphthalimide derivative with potent pro-autophagic effects in human cancer cells. Cancer Research, 2007 May; 67(9) Supplement.
Title: He D, et al. UNBS5162 inhibits the proliferation of esophageal cancer squamous cells via the PI3K/AKT signaling pathway. Mol Med Rep. 2018 Jan;17(1):549-555.